About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
The Bottom Line
- Type 1 respiratory failure = low oxygen with normal/low CO2; causes include pneumonia, pulmonary oedema, PE, ARDS, pneumothorax, ILD
- Type 2 respiratory failure = elevated CO2 from alveolar hypoventilation; causes include COPD, obesity hypoventilation, sedatives/opioids, neuromuscular weakness, severe asthma, chest wall disease
- ABG is the definitive physiology test; VBG is useful for pH/CO2 trends in COPD but does not replace ABG for exact oxygenation
- Oxygen target: 92-96% for most; 88-92% when chronic CO2 retention is known or suspected
- NIV is high-yield for acute hypercapnic COPD with acidosis and cardiogenic pulmonary oedema; intubate if airway protection, exhaustion, refractory hypoxia, shock, or NIV contraindication/failure
Approach to the Presentation
Hypoxia and respiratory failure are physiologic presentations rather than diagnoses. The immediate priorities are airway protection, work of breathing, oxygenation, ventilation, circulation, and reversibility. Determine whether the problem is oxygenation (Type 1), ventilation (Type 2), both, or a non-pulmonary oxygen delivery problem such as anaemia or shock. In MCCQE1 stems, respiratory rate, mental status, speech, accessory muscle use, SpO2, pH, PaCO2, bicarbonate, and CXR findings often point to the next best step. Escalation should be based on trajectory, not a single number.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Severe Asthma / COPD Exacerbation with Hypercapnia | must-not-miss | Wheeze, increased work of breathing, poor air entry, exhaustion, drowsiness. COPD: chronic CO2 retention, sputum change; asthma: rising CO2 is pre-arrest | ABG/VBG showing respiratory acidosis; spirometry later, not during severe instability |
| Pneumonia / Sepsis | must-not-miss | Fever, cough, sputum, focal crackles, hypoxaemia, delirium in older adults; severe disease can cause ARDS | CXR infiltrate, CBC, cultures if severe/admitted, lactate if sepsis |
| Pulmonary Oedema / Acute Heart Failure | must-not-miss | Severe dyspnoea, orthopnoea, crackles, hypertension, frothy sputum, elevated JVP, oedema; may respond dramatically to NIV/nitrates | CXR pulmonary oedema, BNP/NT-proBNP, bedside ultrasound B-lines, ECG/troponin, echo |
| Pulmonary Embolism | must-not-miss | Sudden dyspnoea, pleuritic pain, tachycardia, hypoxia, syncope/shock in massive PE; clear lungs possible | Clinical probability pathway, D-dimer if appropriate, CTPA; bedside echo RV strain if unstable |
| Pneumothorax / Tension Pneumothorax | must-not-miss | Sudden dyspnoea, pleuritic pain, unilateral absent breath sounds; tension adds hypotension/JVD/tracheal deviation late | Clinical for tension; CXR or lung ultrasound if stable |
| ARDS | must-not-miss | Acute hypoxaemia after sepsis, aspiration, pancreatitis, trauma, transfusion; diffuse bilateral infiltrates not fully explained by cardiac failure | ABG PaO2/FiO2 ratio + CXR/CT bilateral opacities + clinical context |
| Opioid/Sedative Toxicity | must-not-miss | Bradypnoea, somnolence/coma, pinpoint pupils with opioids, hypoventilation, hypercapnia; mixed ingestions possible | Clinical + response to naloxone for opioids; ABG/VBG hypercapnia; tox screen supportive |
| Neuromuscular Respiratory Failure | must-not-miss | Weak cough, dysphagia, bulbar symptoms, myasthenia gravis, Guillain-Barré, ALS, spinal cord lesion; may have normal CXR early | FVC/NIF trend, ABG/VBG CO2, neurology assessment; do not rely on SpO2 alone |
| Obesity Hypoventilation Syndrome | common | Obesity, daytime hypercapnia, OSA symptoms, morning headaches, somnolence, pulmonary hypertension/right HF | ABG daytime PaCO2 elevation; sleep study; bicarbonate often elevated chronically |
| Carbon Monoxide Poisoning / Dyshemoglobinaemia | less common | Headache, dizziness, confusion, exposure to fire/heater/garage; pulse oximetry can be falsely normal | Co-oximetry carboxyhaemoglobin/methemoglobin level; ABG PaO2 may be normal |
Red Flags & Key History
Symptoms
Altered mental status, agitation, drowsiness, or inability to protect airway
Unable to speak, exhaustion, silent chest, weak cough, or poor secretion clearance
Sudden onset with pleuritic pain/syncope — PE or pneumothorax
Fever, rigors, productive cough — pneumonia/sepsis
Opioids, benzodiazepines, alcohol, sedatives, neuromuscular disease, obesity hypoventilation risk
Smoke exposure or multiple household members with headache — carbon monoxide
Signs
SpO2 persistently <90% or rapidly increasing oxygen requirement
Respiratory rate very high or paradoxically falling in a tired patient
Cyanosis, diaphoresis, accessory muscle use, tripod positioning
Hypotension/shock — massive PE, sepsis, tension pneumothorax, severe cardiogenic pulmonary oedema
Flapping tremor, somnolence, warm peripheries — hypercapnia
Approach to Investigation
First-line
Pulse oximetry and continuous monitoringTrend oxygen requirement and work of breathing; recognise limitations in CO poisoning, poor perfusion, nail varnish, motion artefact
ABG or VBGABG for oxygenation and A-a physiology; VBG acceptable for pH/CO2 trend in many COPD decisions but cannot accurately determine PaO2
CXRPneumonia, oedema, pneumothorax, effusion, ARDS, hyperinflation, aspiration, malignancy
ECG + basic labsACS/arrhythmia, electrolytes, renal function, CBC for infection/anaemia, glucose, lactate if sepsis/shock, troponin/BNP as indicated
Second-line
Bedside ultrasoundLung sliding, B-lines, effusion, consolidation, RV strain, cardiac function, IVC. Useful when unstable
CTPA / CT chestCTPA for suspected PE; CT chest for unexplained severe hypoxia, ILD, malignancy, complications of pneumonia, or ARDS differential when stable enough
Co-oximetryIf carbon monoxide or methemoglobinaemia suspected; standard pulse oximetry is unreliable
FVC/NIFSerial bedside respiratory muscle measurements for neuromuscular weakness; falling FVC is an airway warning
Specialist
ICU assessmentPersistent hypoxia despite high-flow oxygen, hypercapnic acidosis, shock, altered mental status, need for NIV/intubation, ARDS, neuromuscular weakness
EchocardiographyPulmonary hypertension, RV strain, acute HF, valvular disease, cardiogenic shock
Management Principles
Canadian Thoracic Society respiratory guidance + CAEP/critical care emergency practice1
Immediate support
- Airway positioning, suction, oxygen delivery device matched to severity: nasal cannula, face mask, non-rebreather, high-flow nasal cannula, NIV, or intubation
- Target SpO2 92-96% for most acutely ill patients; 88-92% for known/suspected chronic CO2 retention
- Treat reversible causes immediately: bronchodilators/steroids, antibiotics, diuresis/nitrates/NIV for pulmonary oedema, anticoagulation for PE, decompression for tension pneumothorax, naloxone for opioid toxicity
2
Non-invasive ventilation
- Indicated strongly for acute hypercapnic COPD exacerbation with acidosis if cooperative and protecting airway
- Useful for cardiogenic pulmonary oedema with severe distress
- Contraindications: inability to protect airway, vomiting/high aspiration risk, facial trauma, severe agitation, haemodynamic instability, copious secretions, immediate need for intubation
3
Intubation / invasive ventilation
- Indications: refractory hypoxaemia, worsening acidosis/hypercapnia, exhaustion, altered mental status, shock, airway obstruction, inability to protect airway, NIV failure/contraindication
- Prepare for difficult physiology: preoxygenate, resuscitate shock, choose experienced operator, anticipate post-intubation hypotension
- Lung-protective ventilation for ARDS; avoid high pressures where possible
4
Disposition
- ICU for ventilatory support, persistent high oxygen requirements, ARDS, shock, or rapidly worsening respiratory failure
- Ward/observation for improving patients with stable oxygen needs and clear diagnosis
- Outpatient management only when oxygenation, work of breathing, diagnosis, follow-up, and safety-netting are appropriate
Complications & Pitfalls
- Oxygen saturation tunnel vision: Ventilation failure is about CO2 and pH; a patient can be dangerously hypercapnic with acceptable SpO2.
- Too much oxygen in CO2 retainers: Use controlled oxygen targets in COPD/OHS/neuromuscular chronic hypoventilation.
- Delayed intubation: NIV is not a destination; failing NIV requires escalation before arrest.
- Pulse oximetry false reassurance: CO poisoning can show normal SpO2; use co-oximetry.
- Missing neuromuscular failure: Clear lungs with weak cough and rising CO2 should trigger FVC/NIF monitoring and early ICU involvement.
MCCQE1 Exam Tips
- 1Type 1 = oxygen problem; Type 2 = ventilation/CO2 problem. ABG patterns are often the clue
- 2COPD exacerbation + pH <7.35 + high CO2 = NIV unless contraindicated
- 3Severe asthma with rising/normal CO2 = impending failure; prepare ICU/intubation
- 4Do not use pulse oximetry alone in carbon monoxide poisoning — SpO2 can look normal
- 5Neuromuscular respiratory failure may have normal CXR and normal SpO2 early; serial FVC/NIF is key
- 6Most hypoxic patients target 92-96%; suspected CO2 retainers target 88-92%
- 7CanMEDS leader/collaborator: early ICU/RT involvement is part of correct management, not a sign of failure
practicetest your knowledge on hypoxia & respiratory failureApply what you've learnt with MCCQE1-style questions from the iatroX Q-Bank — respiratory and beyond.
open q-bank